Kite Realty's 52% stake in Legacy West highlights real estate trends with strong Q1 growth. Click here to read an analysis of ...

Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

Kite AI, the decentralized AI Layer-1 platform, today announced a strategic partnership with EigenLayer, the Ethereum-based restaking protocol, to integrating EigenLayer’s restaking technology into ...

H.C. Wainwright lowered the firm’s price target on Innate Pharma (IPHA) to $11 from $11.50 and keeps a Buy rating on the shares. The firm postponed the U.S. launch of IPH6101 to 2029 from ...

Innate Pharma (IPHA) announced a EUR 15M capital increase subscribed by Sanofi (SNY). As announced on April 23 and given the satisfactory market conditions, Sanofi has agreed to subscribe to ...

The prospect of pharma tariffs are also weighing on Roche and Novartis (NVS), which this month announced plans to invest $23 billion in the U.S. Roche has been expanding in the weight-loss drug ...

Kusum Healthcare, owned by Rajiv Gupta, is one of the largest pharma firms operating in Ukraine, playing a key role in supplying basic medicines across the country. Story continues below this ad “On ...

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...

In 2024, Puerto Rico ranked second among U.S. jurisdictions in pharmaceutical and medicine manufacturing exports, accounting for 17.6% of the total U.S. trade dollar value in that category, according ...